Six-month high in D.C. medical cannabis sales
While overall sales haven’t reached pre-Maryland adult-use launch levels, D.C.’s medical cannabis market showed signs of stability in December 2023. Total sales reached nearly $3 million, marking the highest monthly figure since Maryland’s recreational market opened in July.
Interestingly, patients benefiting from reduced licensing fees contributed over $300,000, representing 10% of the total market share. This highlights the program’s accessibility and potential for further growth.
While December 2022 saw overall sales exceeding $4 million, this year’s figures reveal consistent performance in other areas. Cultivation centers and manufacturers reported nearly identical totals compared to December 2022, with a difference of only $79,430.
Furthermore, the amount of flower sold remained relatively unchanged, although revenue increased by $70,000, suggesting slight price adjustments. Notably, 481 pounds of flower and 544 grams of concentrate were sold throughout the month.
December 2023 Highlights
- Six inspections were conducted across dispensaries and cultivation centers with no violations found.
- Patients served grew by almost 500 from November.
- The top state for temporary patient registrations was Maryland for the fourth month in a row followed by Virginia than Florida.
- Straight cannabis bud sales (481lbs) fell for the fourth month straight.
- Fourth quarter 2023 was almost $1 million lower in sales than the same period in 2022.
- 2,200 pounds of cannabis waste was destroyed in December.
- Over 1,800 patient registrations are set to expire by the end of March.
